SMC1A codon 496 mutations affect the cellular response to genotoxic treatments

Linda Mannini, Stefania Menga, Alessandra Tonelli, Silvia Zanotti, Maria Teresa Bassi, Cinzia Magnani, Antonio Musio

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cornelia de Lange syndrome is a pleiotropic developmental syndrome characterized by growth and cognitive impairment, facial dysmorphic features, limb anomalies, and other malformations. Mutations in core cohesin genes SMC1A and SMC3, and the cohesin regulatory gene, NIPBL, have been identified in Cornelia de Lange syndrome probands. Patients with NIPBL mutations have more severe phenotypes when compared to those with mutations in SMC1A or SMC3. To date, 26 distinct SMC1A mutations have been identified in patients with Cornelia de Lange syndrome. Here, we describe a 3-year-old girl with psychomotor and cognitive impairment, mild facial dysmorphic features but no limb anomaly, heterozygous for a c.1487G>A mutation in SMC1A which predicts p.Arg496His. We show that this mutation leads to an impairment of the cellular response to genotoxic treatments.

Original languageEnglish
Pages (from-to)224-228
Number of pages5
JournalAmerican Journal of Medical Genetics, Part A
Volume158 A
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Codon
De Lange Syndrome
Mutation
Therapeutics
Extremities
Psychomotor Disorders
Regulator Genes
Phenotype
Growth
Genes
Cognitive Dysfunction
cohesins

Keywords

  • Cellular response to genotoxic treatments
  • Cornelia de Lange syndrome
  • Recurring mutation
  • SMC1A codon 496

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

SMC1A codon 496 mutations affect the cellular response to genotoxic treatments. / Mannini, Linda; Menga, Stefania; Tonelli, Alessandra; Zanotti, Silvia; Bassi, Maria Teresa; Magnani, Cinzia; Musio, Antonio.

In: American Journal of Medical Genetics, Part A, Vol. 158 A, No. 1, 01.2012, p. 224-228.

Research output: Contribution to journalArticle

Mannini, Linda ; Menga, Stefania ; Tonelli, Alessandra ; Zanotti, Silvia ; Bassi, Maria Teresa ; Magnani, Cinzia ; Musio, Antonio. / SMC1A codon 496 mutations affect the cellular response to genotoxic treatments. In: American Journal of Medical Genetics, Part A. 2012 ; Vol. 158 A, No. 1. pp. 224-228.
@article{c0e68f610fbd425485e48b4a0556eccb,
title = "SMC1A codon 496 mutations affect the cellular response to genotoxic treatments",
abstract = "Cornelia de Lange syndrome is a pleiotropic developmental syndrome characterized by growth and cognitive impairment, facial dysmorphic features, limb anomalies, and other malformations. Mutations in core cohesin genes SMC1A and SMC3, and the cohesin regulatory gene, NIPBL, have been identified in Cornelia de Lange syndrome probands. Patients with NIPBL mutations have more severe phenotypes when compared to those with mutations in SMC1A or SMC3. To date, 26 distinct SMC1A mutations have been identified in patients with Cornelia de Lange syndrome. Here, we describe a 3-year-old girl with psychomotor and cognitive impairment, mild facial dysmorphic features but no limb anomaly, heterozygous for a c.1487G>A mutation in SMC1A which predicts p.Arg496His. We show that this mutation leads to an impairment of the cellular response to genotoxic treatments.",
keywords = "Cellular response to genotoxic treatments, Cornelia de Lange syndrome, Recurring mutation, SMC1A codon 496",
author = "Linda Mannini and Stefania Menga and Alessandra Tonelli and Silvia Zanotti and Bassi, {Maria Teresa} and Cinzia Magnani and Antonio Musio",
year = "2012",
month = "1",
doi = "10.1002/ajmg.a.34384",
language = "English",
volume = "158 A",
pages = "224--228",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - SMC1A codon 496 mutations affect the cellular response to genotoxic treatments

AU - Mannini, Linda

AU - Menga, Stefania

AU - Tonelli, Alessandra

AU - Zanotti, Silvia

AU - Bassi, Maria Teresa

AU - Magnani, Cinzia

AU - Musio, Antonio

PY - 2012/1

Y1 - 2012/1

N2 - Cornelia de Lange syndrome is a pleiotropic developmental syndrome characterized by growth and cognitive impairment, facial dysmorphic features, limb anomalies, and other malformations. Mutations in core cohesin genes SMC1A and SMC3, and the cohesin regulatory gene, NIPBL, have been identified in Cornelia de Lange syndrome probands. Patients with NIPBL mutations have more severe phenotypes when compared to those with mutations in SMC1A or SMC3. To date, 26 distinct SMC1A mutations have been identified in patients with Cornelia de Lange syndrome. Here, we describe a 3-year-old girl with psychomotor and cognitive impairment, mild facial dysmorphic features but no limb anomaly, heterozygous for a c.1487G>A mutation in SMC1A which predicts p.Arg496His. We show that this mutation leads to an impairment of the cellular response to genotoxic treatments.

AB - Cornelia de Lange syndrome is a pleiotropic developmental syndrome characterized by growth and cognitive impairment, facial dysmorphic features, limb anomalies, and other malformations. Mutations in core cohesin genes SMC1A and SMC3, and the cohesin regulatory gene, NIPBL, have been identified in Cornelia de Lange syndrome probands. Patients with NIPBL mutations have more severe phenotypes when compared to those with mutations in SMC1A or SMC3. To date, 26 distinct SMC1A mutations have been identified in patients with Cornelia de Lange syndrome. Here, we describe a 3-year-old girl with psychomotor and cognitive impairment, mild facial dysmorphic features but no limb anomaly, heterozygous for a c.1487G>A mutation in SMC1A which predicts p.Arg496His. We show that this mutation leads to an impairment of the cellular response to genotoxic treatments.

KW - Cellular response to genotoxic treatments

KW - Cornelia de Lange syndrome

KW - Recurring mutation

KW - SMC1A codon 496

UR - http://www.scopus.com/inward/record.url?scp=84355166398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84355166398&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.34384

DO - 10.1002/ajmg.a.34384

M3 - Article

VL - 158 A

SP - 224

EP - 228

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 1

ER -